Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides

Infection and Immunity

Volumn 72, Issue 8, 2004, Pages 4376-4384

  BenMohamed, Lbachir ^a,b,c   Thomas, Alan ^d   Druilhe, Pierre ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD8 ANTIGEN; EPITOPE; IMMUNOLOGICAL ADJUVANT; LIPOPEPTIDE; LSA1 ANTIGEN; LSA3 ANTIGEN; MINERAL OIL; MONTANIDE ISA51 ADJUVANT; SALSA ANTIGEN; SODIUM CHLORIDE; STARP ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CHIMPANZEE; CYTOTOXIC T LYMPHOCYTE; DISEASE MODEL; DRUG FORMULATION; EMULSION; HELPER CELL; IMMUNIZATION; IMMUNOGENICITY; IMMUNOREACTIVITY; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPOROZOITE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNIZATION; LIPOPROTEINS; MALARIA VACCINES; MALARIA, FALCIPARUM; MOLECULAR SEQUENCE DATA; PAN TROGLODYTES; PEPTIDES; PLASMODIUM FALCIPARUM; T-LYMPHOCYTES, CYTOTOXIC;

EID: 3342994925     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.8.4376-4384.2004     Document Type: Article

References (66)

1. Aidoo, M., A. Lalvani, C. E. Allsopp, M. Plebanski, S. J. Meisner, P. Krausa, M. Browning, S. Morris-Jones, F. Gotch, D. A. Fidock, et al. 1995. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345:1003-1007.
2. Aidoo, M., A. Lalvani, S. C. Gilbert, J. T. Hu, P. Daubersies, N. Hurt, H. C. Whittle, P. Druihle, and A. V. Hill. 2000. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liverstage antigen 3. Infect. Immun. 68:227-232.
3. + IFN-γ and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery. J. Immunol. 168:6189-6198.
4. Andrieu, M., J. F. Desoutter, E. Loing, J. Gaston, D. Hanau, J. G. Guillet, and A. Hosmalin. 2003. Two human immunodeficiency virus vaccinal lipopeptides follow different Cross-presentation pathways in human dendritic cells. J. Virol. 77:1564-1570.
5. + T lymphocyte activation. Eur. J. Immunol. 30:3256-3265.
6. Belnoue, E., F. T. Costa, T. Frankenberg, A. M. Vigario, T. Voza, N. Leroy, M. M. Rodrigues, I. Landau, G. Snounou, and L. Renia. 2004. Protective T-cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J. Immunol. 172:2487-2495.
7. BenMohamed, L., Y. Belkaid, E. Loing, K. Brahimi, H. Gras-Masse, and P. Druilhe. 2002. Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant. Eur. J. Immunol. 32:2274-2281.
8. + Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity. J. Virol. 77:9463-9473.
9. BenMohamed, L., H. Gras-Masse, A. Tartar, P. Daubersies, K. Brahimi, M. Bossus, A. Thomas, and P. Druilhe. 1997. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur. J. Immunol. 27:1242-1253.
10. BenMohamed, L., R. Krishnan, C. Auge, J. F. Primus, and D. J. Diamond. 2002. Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses. Immunology 106:113-121.
11. H response. Hum. Immunol. 61:764-779.
12. BenMohamed, L., A. Thomas, M. Bossus, K. Brahimi, J. Wubben, H. Gras-Masse, and P. Druilhe. 2000. High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum preerythrocytic molecules. Vaccine 18:2843-2855.
13. BenMohamed, L., S. L. Wechsler, and A. B. Nesburn. 2002. Lipopeptide vaccines: yesterday, today, and tomorrow. Lancet Infect. Dis. 2:425-431.
14. Bossus, M., L. BeMohamed, A. Londono, B. Barbier, A. Tartar, P. Druilhe, and H. Gras-Masse. 1997. Improved detection of human antibodies to a Plasmodium antigen using a peptide modified with Aib residues. J. Peptide Sci. 3:47-53.
15. Bottius, E., L. BenMohamed, K. Brahimi, H. Gras, J. P. Lepers, L. Raharimalala, M. Aikawa, J. Meis, B. Slierendregt, A. Tartar, A. Thomas, and P. Druilhe. 1996. A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes. J. Immunol. 156:2874-2884.
16. Bowen, J. C., H. O. Alpar, R. Phillpotts, and M. R. Brown. 1992. Mucosal delivery of herpes simplex virus vaccine. Res. Virol. 143:269-278.
17. Bray, R. S. 1960. Studies on malaria in chimpanzees. VIII. The experimental transmission and pre-erythrocytic phase of Plasmodium malariae, with a note on the host-range of the parasite. Am. J. Trop. Med. Hyg. 9:455-465.
18. Charlotte-Gruner, A., G. Snounou, K. Brahimi, F. Letourneur, L. Renia, and P. Druilhe. 2003. Pre-erythrocytic antigens of Plasmodium falciparum: from rags to riches? Trends Parasitol. 19:74-78.
19. Daubersies, P., A. W. Thomas, P. Millet, K. Brahimi, J. A. Langermans, B. Ollomo, L. BenMohamed, B. Slierendregt, W. Eling, A. Van Belkum, G. Dubreuil, J. F. Meis, C. Guerin-Marchand, S. Cayphas, J. Cohen, H. Gras-Masse, and P. Druilhe. 2000. Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nat. Med. 6:1258-1263.
20. Doolan, D. L., R. C. Hedstrom, W. O. Rogers, Y. Charoenvit, M. Rogers, P. de la Vega, and S. L., Hoffman. 1996. Identification and characterization of the protective hepatocyte erythrocyte protein 17-kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. J. Biol. Chem. 271:17861-17868.
21. Doolan, D. L., and S. L. Hoffman. 2000. The complexity of protective immunity against liver-stage malaria. J. Immunol. 165:1453-1462.
22. Doolan, D. L., S. Southwood, R. Chesnut, E. Appella, E. Gomez, A. Richards, Y. I. Higashimoto, A. Maewal, J. Sidney, R. A. Gramzinski, C. Mason, D. Koech, S. L. Hoffman, and A. Sette. 2000. HLA-DR-promiscuous T-cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. J. Immunol. 165:1123-1137.
23. Doolan, D. L., S. Southwood, D. A. Freilich, J. Sidney, N. L. Graber, L. Shatney, L. Bebris, L. Florens, C. Dobano, A. A. Witney, E. Appella, S. L. Hoffman, J. R. Yates III, D. J. Carucci, and A. Sette. 2003. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl. Acad. Sci. USA 100:9952-9957.
24. Elliott, T. J., V. Cerundolo, C. Ohlen, H. G. Ljunggren, K. Karre, and A. Townsend, 1991. Antigen presentation and the association of class-I molecules. Acta Biol. Hung. 42:213-229.
25. Elvin, J., C. Potter, T. Elliott, V. Cerundolo, and A. Townsend. 1993. A method to quantify binding of unlabeled peptides to class I MHC molecules and detect their allele specificity. J. Immunol. Methods 158:161-171.
26. Fidock, D. A., E. Bottius, K. Brahimi, I. I. Moelans, M. Aikawa, R. N. Konings, U. Certa, P. Olafsson, T. Kaidoh, A. Asavanich, et al. 1994. Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP. Mol. Biochem. Parasitol. 64:219-232.
27. Gahery-Segard, H., G. Pialoux, B. Charmeteau, S. Sermet, H. Poncelet, M. Raux, A. Tartar, J. P. Levy, H. Gras-Masse, and J. G. Guillet. 2000. Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine. J. Virol. 74:1694-1703.
28. +-T-cell epitopes recognized. J. Virol. 77:11220-11231.
29. Garnier, A., and L. Tosi. 1978. Circular dichroism investigation of the (L lysine)n-Cu(II) (1:1) systems with n = 4 and n = 25. Bioinorg. Chem. 8: 493-501.
30. Good, M. F., and D. L. Doolan. 1999. Immune effector mechanisms in malaria. Curr. Opin. Immunol. 11:412-419.
31. Higgins, J. A., C. J. Thorpe, J. D. Hayball, R. E. O'Hehir, and J. R. Lamb. 1994. Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. J. Allergy Clin. Immunol. 93:891-899.
32. Hill, A. V., J. Elvin, A. C. Willis, M. Aidoo, C. E. Allsopp, F. M. Gotch, X. M. Gao, M. Takiguchi, B. M. Greenwood, A. R. Townsend, et al. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434-439.
33. Hill, A. V., W. Reece, P. Gothard, V. Moorthy, M. Roberts, K. Flanagan, M. Plebanski, C. Hannan, J. T. Hu, R. Anderson, P. Degano, J. Schneider, E. Prieur, E. Sheu, and S. C. Gilbert. 2000. DNA-based vaccines for malaria: a heterologous prime-boost immunization strategy. Dev. Biol. 104:171-179.
34. Hoffman, S. L., and E. D. Franke. 1994. Inducing protective immune responses against the sporozoite and liver stages of Plasmodium. Immunol. Lett. 41:89-94.
35. Hoffman, S. L., D. Isenbarger, G. W. Long, M. Sedegah, A. Szarfman, S. Mellouk, and W. R. Ballou. 1990. T lymphocytes from mice immunized with irradiated sporozoites eliminate malaria from hepatocytes. Bull. W. H. O. 68(Suppl.):132-137.
36. Hollingdale, M. R., M. Aikawa, G. X. Chen, J. F. Meis, K. Sakhuja, B. Sina, and J. D. Zhu. 1990. Pre-erythrocytic stage malaria parasites: non-circumsporozoite protein antigens. Bull. W. H. O. 68(Suppl.):178-180.
37. Joshi, S. K., P. R. Suresh, and V. S. Chauhan. 2001. Flexibility in MHC and TCR recognition: degenerate specificity at the T-cell level in the recognition of promiscuous Th epitopes exhibiting no primary sequence homology. J. Immunol. 166:6693-6703.
38. Kabilan, L., M. Troye-Blomberg, H. Perlmann, G. Andersson, B. Hogh, E. Petersen, A. Bjorkman, and P. Perlmann. 1988. T-cell epitopes in Pf155/ RESA, a major candidate for a Plasmodium falciparum malaria vaccine. Proc. Natl. Acad. Sci. USA 85:5659-5663.
39. + cytotoxic T-cell clone recognizing sporozoite surface protein 2. Infect. Immun. 62:2979-2983.
40. Lalvani, A., and A. V. Hill. 1998. Cytotoxic T lymphocytes against malaria and tuberculosis: from natural immunity to vaccine design. Clin. Sci. 95:531-538.
41. Lalvani, A., P. Moris, G. Voss, A. A. Pathan, K. E. Kester, R. Brookes, E. Lee, M. Koutsoukos, M. Plebanski, M. Delchambre, K. L. Flanagan, C. Carton, M. Slaoul, C. Van Hoecke, W. R. Ballou, A. V. Hill, and J. Cohen. 1999. Potent induction of focused Thl-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J. Infect. Dis. 180:1656-1664.
42. Leclerc, C., R. Lo-Man, C. Fayolle, A. Charbit, J. M. Clement, P. Martineau, D. O'Callaghan, and M. Hofnung. 1994. Molecular and cellular parameters controlling the immunogenicity of foreign B- or T-cell epitopes expressed by recombinant vectors. Dev. Biol. Stand. 82:193-199.
43. Lunel, F., and P. Druilhe. 1989. Effector cells involved in nonspecific and antibody-dependent mechanisms directed against Plasmodium falciparum blood stages in vitro. Infect. Immun. 57:2043-2049.
44. Mizukoshi, E., M. Nascimbeni, J. B. Blaustein, K. Mihalik, C. M. Rice, T. J. Liang, S. M. Feinstone, and B. Rehermann. 2002. Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies. J. Virol. 76:6093-6103.
45. Pasquetto, V., D. A. Fidock, H. Gras, E. Badell, W. Eling, W. R. Ballou, J. Belghiti, A. Tartar, and P. Druilhe. 1997. Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen. Eur. J. Immunol. 27:2502-2513.
46. Perlaza, B. L., M. Arevalo-Herrera, K. Brahimi, G. Quintero, J. C. Palomino, H. Gras-Masse, A. Tartar, P. Druilhe, and S. Herrera. 1998. Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys. Infect. Immun. 66:3423-3428.
47. Perlaza, B. L., J. P. Sauzet, A. T. Balde, K. Brahimi, A. Tall, G. Corradin, and P. Druilhe. 2001. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T-cell responses in mice. Eur. J. Immunol. 31:2200-2209.
48. Perlaza, B. L., C. Zapata, A. Z. Valencia, S. Hurtado, G. Quintero, J. P. Sauzet, K. Brahimi, C. Blanc, M. Arevalo-Herrera, P. Druilhe, and S. Herrera. 2003. Immunogenicity and protective efficacy of Plasmodium falciparum liver-stage Ag-3 in Aotus lemurinus griseimembra monkeys. Eur. J. Immunol. 33:1321-1327.
49. Perng, G. C., B. Maguen, L. Jin, K. R. Mott, J. Kurylo, L. BenMohamed, A. Yukht, N. Osorio, A. B. Nesburn, G. Henderson, M. Inman, C. Jones, and S. L. Wechsler. 2002. A novel herpes simplex virus type 1 transcript (ALRNA) antisense to the 5′ end of the latency-associated transcript produces a protein in infected rabbits. J. Virol. 76:8003-8010.
50. Pialoux, G., H. Gahery-Segard, S. Sermet, H. Poncelet, S. Fournier, L. Gerard, A. Tartar, H. Gras-Masse, J. P. Levy, and J. G. Guillet. 2001. Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteers. AIDS 15:1239-1249.
51. Plebanski, M., M. Aidoo, H. C. Whittle, and A. V. Hill. 1997. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. J. Immunol. 158:2849-2855.
52. Plebanski, M., and A. V. Hill. 2000. The immunology of malaria infection. Curr. Opin. Immunol. 12:437-441.
53. Plebanski, M., O. Proudfoot, D. Pouniotis, R. L. Coppel, V. Apostolopoulos, and G. Flannery. 2002. Immunogenetics and the design of Plasmodium falciparum vaccines for use in malaria-endemic populations. J. Clin. Investig. 110:295-301.
54. Ravichandran, M., D. L. Doolan, J. Cox-Singh, S. L. Hoffman, and B. Singh. 2000. Research note: HLA degenerate T-cell epitopes from Plasmodium falciparum liver stage-specific antigen 1 (LSA-1) are highly conserved in isolates from geographically distinct areas. Parasite Immunol. 22:469-473.
55. Reece, W. H., M. Plebanski, P. Akinwunmi, P. Gothard, K. L. Flanagan, E. A. Lee, M. Cortina-Borja, A. V. Hill, and M. Pinder. 2002. Naturally exposed populations differ in their T1 and T2 responses to the circumsporozoite protein of Plasmodium falciparum. Infect. Immun. 70:1468-1474.
56. Renia, L., M. M. Rodrigues, and V. Nussenzweig. 1994. Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage. Immunology 82:164-168.
57. Sauzet,J. P.,B. L. Perlaza, K. Brahimi, P. Daubersies, and P. Druilhe. 2001. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge. Infect. Immun. 69:1202-1206.
58. Scheller, L. F., and A. F. Azad. 1995. Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc. Natl. Acad. Sci. USA 92:4066-4068.
59. Sherman, I. W., J. R. Greenan, and P. de la Vega. 1988. Immunofluorescent and immunoelectron microscopic localization of protein antigens in red cells infected with the human malaria Plasmodium falciparum. Ann. Trop. Med. Parasitol. 82:531-545.
60. Singh, M., and D. T. O'Hagan. 2002, Recent advances in vaccine adjuvants, Pharm. Res. 19:715-728.
61. Theobald, M., T. Ruppert, U. Kuckelkorn, J. Hernandez, A. Haussler, E. A. Ferreira, U. Liewer, J. Biggs, A. J. Levine, C. Huber, U. H. Koszinowski, P. M. Kloetzel, and L. A. Sherman. 1998. The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope. J. Exp. Med. 188:1017-1028.
62. Turner, J. L., R. J. Trauger, A. E. Daigle, and D. J. Carlo. 1994. HIV-1 immunogen induction of HIV-1-specific delayed-type hypersensitivity: results of a double-blind, adjuvant-controlled, dose-ranging trial. AIDS 8:1429-1435.
63. Uhl, B., V. Speth, B. Wolf, G. Jung, W. G. Bessler, and S. Hauschildt. 1992. Rapid alterations in the plasma membrane structure of macrophages stimulated with bacterial lipopeptides. Eur. J. Cell Biol. 58:90-98.
64. Vichier-Guerre, S., R. Lo-Man, L. BenMohamed, E. Deriaud, S. Kovats, C. Leclerc, and S. Bay. 2003. Induction of carbohydrate-specific antibodies in HLA-DR transgenic mice by a synthetic glycopeptide: a potential anti-cancer vaccine for human use. J. Pept. Res. 62:117-124.
65. Widmann, C., J. L. Maryanski, P. Romero, and G. Corradin. 1991. Differential stability of antigenic MHC class I-restricted synthetic peptides. J. Immunol. 147:3745-3751.
66. Wizel, B., R. Houghten, P. Church, J. A. Tine, D. E. Lanar, D. M. Gordon, W. R. Ballou, A. Sette, and S. L. Hoffman. 1995. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein 2 epitopes in sporozoite-immunized volunteers. J. Immunol. 155:766-775.